BPIQ Blog

Apr 28, 20231 min read

Biopharma Pulse: 4/24-4/28 Weekly Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Apr 28, 20233 min read

Big Movers in Q2... Which Indications are Most Common?

Summary There are four common indications seen in Q2 Big/Suspected Movers NASH/Liver disease, kidney disease, eye disease, and mental...

Apr 28, 20231 min read

Many Exciting Q1 2023 Reports Coming!

Summary: Q1 2023 quarterly financial reports have started! Many large cap biotechs have already reported, and we expect most of the...

Apr 27, 20232 min read

ASCO 2023 Titles Released Yesterday!

First published 5/5/23 Summary: The American Society of Clinical Oncology Annual Meeting is taking place from June 2-6, 2023 This annual...

Apr 19, 20233 min read

How did Companies Perform at AACR 2023?

First published 4/19/23 Summary: AACR wrapped up today with just a couple presentations and investor calls Which companies performed best...

Apr 18, 20234 min read

A Busy Last Week of April for PDUFAs!

Summary: As we are almost in the last week of April, many PDUFA decisions are still to come! Next week will be busy for PDUFAs, with 6...

Apr 16, 20231 min read

Biotech Stock Catalyst Watchlist - April 2023

AACR kicked off this weekend. 8 PDUFA events left in April. Other meeting/events happening as well. See the full table below. Connect...

Apr 14, 20231 min read

Biopharma Pulse: 4/17-4/21 Weekly Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Apr 14, 20231 min read

Biopharma Pulse - 4/10-4/14 Weekly Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Apr 14, 20234 min read

Hedge Fund Top Holdings - Q3 & Q4 '22

Summary: Every quarter we look at the 36 life science hedge funds to determine patterns and to see which tickers are most held by hedge...

Apr 7, 20231 min read

Biotech Stock Catalyst Watchlist - April 2023

The first week of April didn't have too many major events, although $IFRX did move +183% on Emergency Use Authorization. Looking forward,...

Apr 7, 20231 min read

Biopharma Pulse - 4/3 - 4/7 Weekly Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Apr 6, 20234 min read

Which April '23 PDUFAs are Seeing Run-Ups into Approval Decisions?

What Are We Looking At: There are six PDUFA dates in April 2023 for small to large cap biotech. However, a majority of these upcoming...

Apr 3, 20232 min read

How Did Q1 Hedge Fund Top 20 Returns Compare to Other Quarters?

Summary: We previously analyzed the 36 life science hedge funds to determine which smid-cap biopharmas were in the most Top 20s See our...

Apr 2, 20231 min read

Biotech Stock Catalyst Watchlist - April 2023

We've reached the end of Q1. April has a lot of events happening including 8 PDUFA's, the AACR cancer meeting, and some other company...

Mar 31, 20231 min read

Biopharma Pulse - 3/27 - 3/31 Weekly Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Mar 29, 20232 min read

AACR Starts April 14th!

Last updated 4/10/23 Summary: AACR is only a few weeks away - the conferences starts April 14th, also when abstract text is released What...

Mar 28, 20232 min read

AMGN v. Sanofi Ab Patent Case - What Biotech Investors Should Know

Amgen v. Sanofi Sup Ct. oral arguments took place yesterday in the ongoing PCSK9* antibody (Ab) patent case. See the attached transcript...

Mar 24, 20231 min read

Biotech Q1 '23 Final Catalyst Countdown

We've reached the final week of Q1. Anything that hasn't read out yet is coming this week! There's over 20 events still set to happen....

Mar 24, 20231 min read

Biopharma Pulse - 3/20 - 3/24 Weekly Review

Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...

Jump start your biotech due diligence

Get started →

Our platform helps you uncover your next biotech investment opportunity